Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine and Adrenaline for Skin Graft Donor Sites
NCT04344483Completed
- Sponsor
- Dow University of Health Sciences
- Start
- Dec 2019
- Primary completion
- Jun 2020
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of lidocaine 10% oropharyngeal spray and epinephrine (2 arms), sponsored by Dow University of Health Sciences. Primary endpoints: Intraoperative bleeding, Post operative bleeding at 24 hours and 2 more. Started Dec 2019; status: completed.
02
Drugs
lidocaine 10% oropharyngeal sprayepinephrine
Beyond the preview
Go deeper on NCT04344483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04344483.